Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,934 | 5,030 | 8,173 | 6,661 | 5,624 |
| Receivables | 22,271 | 22,010 | 21,463 | 22,128 | 22,424 |
| Inventories | 25,288 | 26,557 | 25,087 | 25,739 | 25,644 |
| Other current assets | 0 | 0 | 3,109 | 0 | 0 |
| TOTAL | $52,493 | $53,597 | $57,832 | $54,528 | $53,692 |
| Non-Current Assets | |||||
| PPE Net | 5,359 | 5,582 | 5,898 | 5,392 | 5,493 |
| Intangibles | 99,139 | 101,594 | 103,068 | 103,149 | 104,394 |
| Other Non-Current Assets | 9,247 | 10,563 | 1,815 | 1,971 | 1,471 |
| TOTAL | $113,745 | $117,739 | $110,781 | $110,512 | $111,358 |
| Total Assets | $166,238 | $171,336 | $168,613 | $165,040 | $165,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,407 | 2,207 | 5,982 | 1,799 | 1,621 |
| Accounts payable and accrued liabilities | 6,041 | 7,311 | 7,359 | 5,392 | 7,718 |
| Accrued Expenses | 4,876 | 6,716 | 978 | 6,877 | 7,789 |
| Other current liabilities | 1,710 | 1,895 | 7,350 | 1,926 | 1,519 |
| TOTAL | $20,861 | $24,141 | $25,489 | $19,261 | $22,194 |
| Non-Current Liabilities | |||||
| Long Term Debt | 52,414 | 54,135 | 54,813 | 59,247 | 59,828 |
| Deferred Revenues | 3,532 | 3,715 | 3,820 | 3,267 | 3,547 |
| Other Non-Current Liabilities | 10,324 | 10,422 | 3,286 | 3,451 | 4,060 |
| TOTAL | $65,047 | $66,846 | $60,400 | $64,820 | $65,844 |
| Total Liabilities | $85,908 | $90,987 | $85,889 | $84,081 | $88,038 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,046 | 37,688 | 37,668 | 37,294 | 36,580 |
| Common Shares | 436 | 436 | 436 | 435 | 427 |
| Retained earnings | -122,506 | -122,259 | -119,889 | -122,751 | -122,495 |
| Other shareholders' equity | -13,849 | -13,375 | -13,200 | -11,255 | -11,830 |
| TOTAL | $80,330 | $80,349 | $82,724 | $80,959 | $77,012 |
| Total Liabilities And Equity | $166,238 | $171,336 | $168,613 | $165,040 | $165,050 |